Management of nonischemic-dilated cardiomyopathies in clinical practice: a position paper of the working group on myocardial and pericardial diseases of Italian Society of Cardiology

Abstract

Nonischemic-dilated cardiomyopathy (NIDCM) is an entity that gathers extremely heterogeneous diseases. This awareness, although leading to continuous improvement in survival, has increased the complexity of NIDCM patients’ management. Even though the endorsed ‘red-flags’ approach helps clinicians in pursuing an accurate etiological definition in clinical practice, it is not clear when and how peripheral centers should interact with referral centers with specific expertise in challenging scenarios (e.g. postmyocarditis and genetically determined dilated cardiomyopathy) and with easier access to second-line diagnostic tools and therapies. This position paper will summarize each step in NIDCM management, highlighting the multiple interactions between peripheral and referral centers, from first-line diagnostic workup and therapy to advanced heart failure management and long-term follow-up.

Serum albumin and prognosis in elderly patients with nonischemic dilated cardiomyopathy

“…NIDCM is a heterogeneous heart muscle disease and one of the most important causes of heart failure. 6 , 14 The molecular basis of the irregular cardiac architecture in DCM involves changes in the structure and composition of cardiomyocytes, which lead to remodeling of the myocardium. 15 The outcome of NIDCM is significantly associated with LV remodeling and whether cardiac function is improved by conventional therapy.…”

Clinical Care of Hyperthyroidism Using Wearable Medical Devices in a Medical IoT Scenario

“…e construction of smart medical applications based on IoT technology, including mobile medical care, medical equipment management, and smart hospital service system, was elaborated to gradually realize the combination of IoT and medical services [10]. e purpose of cancer treatment is not only to prolong survival time but also to maintain and improve the quality of survival, which is not only in line with the natural law of cancer development but also consistent with the humanistic concept of "people-oriented" advocated by the state [11]. e evaluation of the quality of survival of cancer patients has become an important aspect of cancer care, but previously it mainly focused on common tumors such as gastric cancer, lung cancer, and breast cancer [12].…”

Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)

“…As for other fields of Cardiology, the concept of a dedicated, multidisciplinary team is emerging as the best strategy to provide state-of-theart, tailored treatment to patients with cardiomyopathies. A multidisciplinary team with specific expertise in inherited and rare CMPs (Graphical Abstract) has the potential to improve diagnostic work-up, standardize and evolve clinical practice, as well as fully exploit the variety of available treatment options [5]. The variety of aetiologies, clinical presentations, and decision-making hubs, characterizing heart muscle disease, determines a degree of complexity that overcomes individual expertise, even in best case scenarios.…”